Suppr超能文献

脂质过氧化物作为骨髓移植受者自由基活性指标的初步观察

Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Preliminary observations.

作者信息

Hunnisett A, Davies S, McLaren-Howard J, Gravett P, Finn M, Gueret-Wardle D

机构信息

London Clinic, UK.

出版信息

Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):125-32. doi: 10.1007/BF02790109.

Abstract

It has been previously demonstrated that the conditioning therapy given to bone marrow transplant (BMT) recipients creates a high oxidant stress, resulting in a measured reduction in antioxidants, such as glutathione peroxidase (GSH-Px), vitamin E, and cell peroxide fragilities. As part of a current intervention trial of antioxidant therapy in BMT recipients, plasma thiobarbituric acid reactive substances (TBARS) were measured to assess peroxidation and free radical activity. Measurements were performed before and after conditioning therapy, and then at weekly intervals for a period of 6 wk after transplantation in 20 patients (10 controls and 10 antioxidant therapy [AOT] recipients). The TBARS results were compared with concurrent measurements of more specific elements of the antioxidant pathways, such as red blood cell glutathione peroxidase (RBC-GSH-Px), plasma vitamin C, and serum vitamin E. In all cases, TBARS concentration was significantly increased after conditioning compared with baseline levels (p < 0.001), an increase that correlated inversely with RBC-GSH-Px (r = -0.81; p < 0.01). The TBARS concentration fell gradually after conditioning in all patients. The fall in the AOT group was more rapid than in the control group, and it paralleled the gradual return toward normal levels of the other antioxidants. The change in TBARS concentration occurred faster than changes in other indices, suggesting that TBARS might be a better index of overall free radical activity. Although the patient numbers are small, there is some evidence to suggest that MDA may act as a prognostic marker.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

先前已证明,给予骨髓移植(BMT)受者的预处理疗法会产生高氧化应激,导致抗氧化剂(如谷胱甘肽过氧化物酶(GSH-Px)、维生素E)水平实测下降,以及细胞对过氧化物的脆弱性增加。作为当前BMT受者抗氧化剂疗法干预试验的一部分,测量了血浆硫代巴比妥酸反应性物质(TBARS)以评估过氧化和自由基活性。在20例患者(10例对照和10例抗氧化剂疗法[AOT]受者)中,在预处理疗法前后进行测量,然后在移植后6周内每周进行一次测量。将TBARS结果与抗氧化途径更具体成分的同时测量结果进行比较,如红细胞谷胱甘肽过氧化物酶(RBC-GSH-Px)、血浆维生素C和血清维生素E。在所有情况下,与基线水平相比,预处理后TBARS浓度显著升高(p<0.001),这种升高与RBC-GSH-Px呈负相关(r=-0.81;p<0.01)。所有患者预处理后TBARS浓度逐渐下降。AOT组的下降比对照组更快,并且与其他抗氧化剂逐渐恢复到正常水平平行。TBARS浓度的变化比其他指标的变化更快,表明TBARS可能是整体自由基活性的更好指标。尽管患者数量较少,但有一些证据表明丙二醛(MDA)可能作为一种预后标志物。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验